The Supplementary Information file originally published with this Article contained incorrect Figures for the ‘NMR spectra of all new compounds’. This error has now been corrected in the Supplementary Information file that accompanies the Article.
A major impediment to the development of therapies with mesenchymal stem cells/multipotent stromal cells (MSC) is the poor survival and engraftment of MSCs at the site of injury. We hypothesized that lowering the energetic demand of MSCs by driving them into a quiescent state would enhance their survival under ischemic conditions. Human MSCs (hMSCs...
Valentini, GabrieleIudici, MicheleWalker, Ulrich AJaeger, Veronika KBaron, MurrayCarreira, PatriciaCzirják, LászlóDenton, Christopher PDistler, OliverHachulla, Eric
...
BACKGROUND Validity of European Scleroderma Study Group (EScSG) activity indexes currently used to assess disease activity in systemic sclerosis (SSc) has been criticised. METHODS Three investigators assigned an activity score on a 0-10 scale for 97 clinical charts. The median score served as gold standard. Two other investigators labelled the dise...
